Amanote Research

Amanote Research

    RegisterSign In

Idarucizumab Dosing in Kidney Failure

American Journal of Kidney Diseases - United Kingdom
doi 10.1053/j.ajkd.2017.08.012
Full Text
Open PDF
Abstract

Available in full text

Categories
Nephrology
Date

January 1, 2018

Authors
Luke YipJou-Fang Deng
Publisher

Elsevier BV


Related search

Idarucizumab Dosing in Patients With Excessive Dabigatran Body Burden

British Journal of Anaesthesia
AnesthesiologyPain Medicine
2019English

Warfarin Dosing in Patients With Impaired Kidney Function

American Journal of Kidney Diseases
Nephrology
2010English

Kidney Failure

JAMA - Journal of the American Medical Association
Medicine
2009English

Dosing of Renal Replacement Therapy in Acute Kidney Injury

American Journal of Kidney Diseases
Nephrology
2012English

Genotype-Guided Tacrolimus Dosing in African-American Kidney Transplant Recipients

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2015English

GFR Measurement and Chemotherapy Dosing in Patients With Kidney Disease and Cancer

Kidney360
2020English

Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children

Clinical Pharmacokinetics
Pharmacology
2015English

Dosing Recommendations Based on Population Pharmacokinetics of Tacrolimus in Mexican Adult Patients With Kidney Transplant

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2018English

Optimization of Dosing Regimens and Dosing in Special Populations

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy